Anyone know where this all stands currently? I'm assuming Rengenexx can still treat patients present. The FDA's involvement in this matter is absolutely absurd.
In my opinion
the FDA is being "strong-armed" by pharma companies who want this potentially lucrative market to themselves. For those out-of-the-loop: this happens a lot.
Keep in mind, I say this as someone who is unaffiliated with either Dr. Centeno, his associates, or any pharmaceutical company.
This development does concern me, because if autologous stem cells can be labeled a drug, then it's a slippery slope to worse things.. but that's a tangent about which a book can be written.